Ulamaa

Ulamaa is an AI-native clinical trial intelligence company that provides a platform for optimizing drug development workflows. The company utilizes large language models (LLMs) to analyze clinical protocols, regulatory documents, and real-world data to help pharmaceutical companies design better trials and select high-performing sites. By automating the synthesis of complex clinical information, Ulamaa aims to accelerate the timeline for clinical research and improve the probability of technical and regulatory success. The platform is designed to be used by clinical operations and data science teams at pharmaceutical firms and contract research organizations.